| Symbol | PKTX |
|---|---|
| Name | PROTOKINETIX, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 44618 United States OH 109 W Main St |
| Telephone | 330-455-4971 |
| Fax | — |
| — | |
| Website | http://www.protokinetix.com |
| Incorporation | US |
| Incorporated On | 1999 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Davidson & Company LLP; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001128189 |
| Description | ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. Additional info from OTC: |
No news found.